Century Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IPSC and other ETFs, options, and stocks.

About IPSC

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. 

CEO
Brent Pfeiffenberger
CEOBrent Pfeiffenberger
Employees
150
Employees150
Headquarters
Philadelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded
2018
Founded2018
Employees
150
Employees150

IPSC Key Statistics

Market cap
47.85M
Market cap47.85M
Price-Earnings ratio
-1.95
Price-Earnings ratio-1.95
Dividend yield
—
Dividend yield—
Average volume
1.21M
Average volume1.21M
High today
$0.5643
High today$0.5643
Low today
$0.5501
Low today$0.5501
Open price
$0.5605
Open price$0.5605
Volume
212.42K
Volume212.42K
52 Week high
$3.29
52 Week high$3.29
52 Week low
$0.3418
52 Week low$0.3418

Analyst ratings

86%

of 7 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

People also own

Based on the portfolios of people who own IPSC. This list is generated using Robinhood data, and it’s not a recommendation.
Mersana Therapeutics
Ovid Therapeutics
Caribou Biosciences
Plug Power
Bitfarms
Adaptimmune Therapeutics
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.